Peter Boman Samuelsen

PersonUnit number: 4303651

Rungsted Kyst

Ownership

Board positions

Director positions

Other roles

People in network

Bankruptcy relations

People in network(77)

People who held roles at the same companies, or who co-own the same companies

Per Ølund

ICTALCARE A/S, ICTALCARE A/S, CUTISENSE A/S, CUTISENSE A/S

Stig Visti Andersen

ACARIX A/S, VentriJect ApS, VentriJect ApS

Philip Kjær

INTERFACE BIOTECH A/S, INTERFACE BIOTECH A/S

Ownership(1)

VentriJect ApS

CVR: 39424371

EJERREGISTER

10-14,99%

Ownership

Active

Board positions(1)

VentriJect ApS

CVR: 39424371

FORMAND

Active

Since 30. jun. 2021

Other roles(2)

VentriJect ApS

CVR: 39424371

STIFTERE

Active

Since 7. mar. 2018

ACARIX A/S

CVR: 32648223

EJERREGISTER

Active

Former board positions(9)

Wear&Care ApS

CVR: 34607834

BESTYRELSESMEDLEM

Ended

Since 11. dec. 2017

Until 24. okt. 2019

ACARIX A/S

CVR: 32648223

BESTYRELSESMEDLEM

Ended

Since 12. dec. 2016

Until 1. aug. 2017

IDEABILITY ApS

CVR: 36431504

BESTYRELSESMEDLEM

Dissolved

Ended

Since 29. okt. 2015

Until 3. apr. 2018

Anpartsselskab 2013

CVR: 35400540

BESTYRELSESMEDLEM

Dissolved

Ended

Since 12. maj 2014

Until 23. aug. 2021

AMPHIDEX A/S

CVR: 33246870

BESTYRELSE

Dissolved

Ended

Since 16. jan. 2013

Until 2. maj 2016

CUTISENSE A/S

CVR: 30235304

formand

Dissolved

Ended

Since 18. feb. 2008

Until 22. dec. 2010

INTERFACE BIOTECH A/S

CVR: 21167134

BESTYRELSE

Bankruptcy

Ended

Since 28. sep. 2007

Until 25. jan. 2011

ICTALCARE A/S

CVR: 30236661

BESTYRELSESMEDLEM

Ended

Since 26. jan. 2007

Until 19. jan. 2009

NORDIC VACCINE A/S

CVR: 26064430

BESTYRELSE

Dissolved

Ended

Since 4. dec. 2006

Until 23. okt. 2008

Former director positions(2)

VentriJect ApS

CVR: 39424371

ADM. DIR.

Ended

Since 2. jun. 2022

Until 31. dec. 2022

ACARIX A/S

CVR: 32648223

DIREKTØR

Ended

Since 1. dec. 2009

Until 1. sep. 2013

Former roles(1)

Psabo v/Peter Boman Samuelsen

CVR: 35736263

INTERESSENTER

Dissolved

Ended

Since 1. apr. 2014

Until 29. feb. 2024